home / stock / cntx / cntx news


CNTX News and Press, Context Therapeutics Inc.

Stock Information

Company Name: Context Therapeutics Inc.
Stock Symbol: CNTX
Market: NASDAQ
Website: contexttherapeutics.com

Menu

CNTX CNTX Quote CNTX Short CNTX News CNTX Articles CNTX Message Board
Get CNTX Alerts

News, Short Squeeze, Breakout and More Instantly...

CNTX - Context Therapeutics: Acquired Asset CT-95 Could Enhance T-Cell Engager Pipeline

2024-07-10 14:06:41 ET Summary Context Therapeutics Inc.'s acquisition of CT-95, targeting MSLN expressing solid tumors, brings another shot on goal for its pipeline of T cell engagers. CTIM-76 is another T cell engager in the pipeline; however, it is being developed to go after o...

CNTX - Context Therapeutics acquires phase 1-ready T cell engager CT-95

2024-07-10 09:02:45 ET More on Context Therapeutics Context Therapeutics stock jumps on $100M private placement Seeking Alpha’s Quant Rating on Context Therapeutics Historical earnings data for Context Therapeutics Financial information for Context The...

CNTX - Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

CT-95 is a potentially first-in-class mesothelin x CD3 bispecific antibody Acquisition expands Context pipeline with second clinical-stage T cell engager for solid tumors PHILADELPHIA, July 10, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the ...

CNTX - Hypergrowth Hits: 3 Stocks Clocking Triple-Digit Gains with No End in Sight 

2024-05-30 06:11:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Hypergrowth stocks are the holy grail of traders and growth investors. These stocks can multiply a small position by two, five, 10 times, or more. In many cases, analysts like to project what s...

CNTX - Context Therapeutics GAAP EPS of -$0.23

2024-05-09 11:36:23 ET More on Context Therapeutics Context Therapeutics stock jumps on $100M private placement Seeking Alpha’s Quant Rating on Context Therapeutics Historical earnings data for Context Therapeutics Financial information for Context The...

CNTX - Context Therapeutics Reports First Quarter 2024 Operating and Financial Results

Announced FDA clearance of IND application for a Phase 1 clinical trial of CTIM-76 Completed $100 million financing; expected to extend funding into 2028 PHILADELPHIA, May 08, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”...

CNTX - Expected US Company Earnings on Wednesday, May 8th, 2024

Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...

CNTX - AEON, SGBX and APVO among pre-market losers

2024-05-03 08:36:49 ET More on pre-market losers & stocks. Safe & Green signs deal for design and production of eight units, currently in concept stage Seeking Alpha’s Quant Rating on AEON Biopharma, Inc. Historical earnings data for AEON Biopharma, In...

CNTX - Lunch Time Pitch

2024-05-02 12:58:43 ET DENVER, Colo., May 02, 2024 ( 247marketnews.com )- Brera Holdings (NASDAQ: BREA ) , Emergent BioSolutions Inc. (NYSE: EBS ), Aspen Aerogels, Inc. (NYSE: ASPN ), Allarity Therapeutics, Inc. (NASDAQ: ALLR ), and ...

CNTX - CytomX Therapeutics, Allarity Therapeutics, Pulmonx among healthcare movers

2024-05-02 10:00:43 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 19 out...

Next 10